HomeARDS • OTCMKTS
add
Aridis Pharmaceuticals Inc
Previous close
$0.00
Market cap
40.00 USD
Avg Volume
12.81K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Revenue | 417.00K | 4.51% |
Operating expense | 1.11M | -34.38% |
Net income | -83.00K | 98.99% |
Net profit margin | -19.90 | 99.04% |
Earnings per share | — | — |
EBITDA | -810.00K | 88.88% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 35.00K | -98.14% |
Total assets | 6.53M | -46.09% |
Total liabilities | 18.34M | -61.75% |
Total equity | -11.80M | — |
Shares outstanding | 44.57M | — |
Price to book | -0.00 | — |
Return on assets | -33.38% | — |
Return on capital | 27.89% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2023info | Y/Y change |
|---|---|---|
Net income | -83.00K | 98.99% |
Cash from operations | -983.00K | 76.95% |
Cash from investing | 0.00 | — |
Cash from financing | 999.00K | 280.32% |
Net change in cash | 16.00K | 100.33% |
Free cash flow | -2.10M | -3.59% |
About
Founded
2003
Headquarters
Website
Employees
37
